Meera Ravindranathan, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Dr. Meera Ravindranathan graduated from the Virginia Commonwealth University School of Medicine and completed her residency and fellowship program at the University of Texas Medical Branch Hospitals. She is specialized in Medical Oncology and board certified in Internal Medicine and Oncology. Dr. Ravindranathan has been in practice for more than 11 years and is affiliated with the Sharp Chula Vista Medical Center and the Sharp Coronado Hospital. During her career, she has also contributed to 3 research publications.
Virginia Commonwealth University School of Medicine
Medical School
University of Texas Medical Branch Hospitals
Residency
University of Texas Medical Branch Hospitals
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
CA State Medical License 2009 - 2017
Sharp Chula Vista Medical Center
Languages: English/Spanish
(619) 502-5800
751 Medical Center Ct
Read MoreSharp Grossmont Hospital
Languages: English/Spanish
(619 )740-6000
5555 Grossmont Center Dr
Read MoreResponse of intracranial metastases to erlotinib therapy.
Fekrazad, M. H., Ravindranathan, M., Jones, D. V.; J Clin Oncol. 2007 Nov 1
See more >>A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies.
Bauman, J., Verschraegen, C., Belinsky, S., Muller, C., Rutledge, T., Fekrazad, M., Ravindranathan, M., Lee, S. J., Jones, D.; Cancer Chemother Pharmacol. 2012 Feb.
See more >>A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers.
Bauman, J.,Shaheen, M.,Verschraegen, C. F.,Belinsky, S. A.,Houman Fekrazad, M.,Lee, F. C.,Rabinowitz, I.,Ravindranathan, M.,Jones, D. V.; Transl Oncol. 2014 Apr 22.
See more >>